|
WO2009003889A2
|
|
Immunogenic analogues of rankl
|
|
WO2008040759A1
|
|
Method for down-regulation of cripto
|
|
WO2007137586A2
|
|
Random insertion of peptides
|
|
AU2006312847A1
|
|
Therapeutic vaccines targeting HMGB1
|
|
US2008253993A1
|
|
Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope
|
|
EP1913143A1
|
|
Improved protein expression
|
|
US2007184023A1
|
|
Method for down-regulation of vegf
|
|
NZ544017A
|
|
A method for purification of an EGFR family derived protein recombinantly produced in an insect cell culture.
|
|
KR20060033870A
|
|
Purification of her-2 variants
|
|
ZA200403686B
|
|
Immunogenic mimetics of multimer proteins with promiscuous T cell epitope inserts
|
|
CA2524623A1
|
|
Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation
|
|
CN1784421A
|
|
Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation
|
|
CN1729202A
|
|
Targeting single epitopes
|
|
KR20050085605A
|
|
Targeting single epitopes
|
|
AU2003285280A1
|
|
Targeting single epitopes
|
|
KR20050052499A
|
|
Immunization against autologous ghrelin
|
|
EP1539232A1
|
|
Immunization against autologous ghrelin
|
|
ZA200306422B
|
|
Synthetic vaccines comprising polyhydroxypolymer carriers.
|
|
AU2003208314A1
|
|
Novel application of vaccination against tnf-alpha
|
|
EP1467751A2
|
|
Immunogenic cea
|
